Henry Schein, Inc. (NASDAQ:HSIC) Position Increased by Smartleaf Asset Management LLC

Smartleaf Asset Management LLC increased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 23.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 759 shares of the company’s stock after acquiring an additional 143 shares during the period. Smartleaf Asset Management LLC’s holdings in Henry Schein were worth $52,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. CIBC Asset Management Inc raised its holdings in Henry Schein by 1.0% during the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock valued at $1,235,000 after buying an additional 169 shares in the last quarter. Studio Investment Management LLC raised its holdings in Henry Schein by 3.8% during the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after buying an additional 172 shares in the last quarter. Metis Global Partners LLC raised its holdings in Henry Schein by 4.7% during the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock valued at $291,000 after buying an additional 187 shares in the last quarter. Central Pacific Bank Trust Division raised its holdings in Henry Schein by 2.0% during the fourth quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock valued at $706,000 after buying an additional 200 shares in the last quarter. Finally, Sanctuary Advisors LLC raised its holdings in Henry Schein by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company’s stock valued at $294,000 after buying an additional 203 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have weighed in on HSIC shares. UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Barrington Research reissued an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Wells Fargo & Company assumed coverage on Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price on the stock. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and boosted their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Mizuho started coverage on Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $75.45 on Tuesday. The firm has a fifty day moving average of $74.57 and a two-hundred day moving average of $72.59. The stock has a market capitalization of $9.37 billion, a price-to-earnings ratio of 31.05, a PEG ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.66 EPS. As a group, equities research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.